ISRCTN70307341
Active, not recruiting
未知
BabyBreathe Trial: a randomized controlled trial of a complex intervention to prevent return to smoking postpartum
niversity of East Anglia0 sites880 target enrollmentMarch 23, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of East Anglia
- Enrollment
- 880
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
2023 Protocol article in https://doi.org/10.1136/bmjopen-2023-076458 (added 05/09/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Pregnant women who have stopped smoking completely in the 12 months prior to pregnancy, or at any time during pregnancy
- •2\. At 26 weeks gestation or any time up until birth, woman confirms having not smoked a single puff of a cigarette for at least 4 weeks.
- •3\. Able to read and understand English
- •4\. Willing and able to give informed consent for participation in the study
- •5\. Smoking abstinence confirmed by expired carbon monoxide (CO) reading less than 4ppm
Exclusion Criteria
- •1\. Under the age of 16
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 3
Antenatal corticosteroids for planned birth in twinsISRCTN59959611niversity of Edinburgh1,552
Completed
Phase 3
Phase III randomised controlled trial of a breathlessness intervention service for intractable breathlessnessRespiratoryIntractable breathlessness, malignant and non-malignant conditionsAbnormalities of breathingISRCTN04119516Cambridge University Hospitals NHS Foundation Trust (UK)120
Completed
Not Applicable
Comparison Of Respiratory Support After Delivery on Infants Born Before 28 Weeks Gestational AgeRespiration; Insufficient or Poor, NewbornInfant, Premature, DiseasesNCT02563717Baldvin Jonsson250
Completed
Not Applicable
Buteyko Based Remedial Breathing Therapy With Children With AsthmaAsthmaNCT02140086ARCIM Institute Academic Research in Complementary and Integrative Medicine32
Active, not recruiting
Phase 1
A randomised controlled trial in preterm infants comparing prophylactic with selective Less Invasive Surfactant Administration” (pro.LISA)Respiratory distress syndrome in preterm infantsTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]CTIS2024-516504-42-00niversitaetsklinikum Schleswig-Holstein AöR698